Abstract
The main adverse consequences of excess bodyweight are cardiovascular disease, type II diabetes, and several cancers, IL-1Ra serum concentration has been reported earlier to increase in human obesity and it is therefore assumed that the polymorphism of IL-1Ra may influence cytokine production. We designed this study to investigate whether the IL-1Ra polymorphism was associated with obesity. A total number of 103 individuals; 19 lean (BMI<25 Kg/m2), 51 overweight (BMI 25–29.9 Kg/m2) and 33 obese (BMI≥30.0 Kg/m2) were enrolled in this study. Genotyping was performed using a polymerase chain reaction PCR amplification of the intron-2 fragment harboring a variable number of tandem repeat (VNTR) nucleotide sequences 86 pb of tandem repeat. The PCR products were separated on 2% agarose gel. Statistical analysis was performed using SPSS software (version 11.5). We found no significant difference in genotype and allele frequencies between the three groups; lean vs. overweight and lean vs. obese (p=0.323; 0.202; 0.123 and 0.068 resp). However, an increased risk for obesity had a propensity to be higher in those having genotype II/II. This genotype has been reported to be a ‘high producer’ of IL-1Ra. Although no statistically significant relationship between IL-1Ra polymorphism and BMI was observed, however, a trend towards an increase of allele*II in overweight and obese group was observed. This may suggest that IL-1Ra appears to be induced by inflammatory stimuli as well as obesity-associated factors. This is relatively a pilot study: but nevertheless, may assist in identifying the pathophysiological cause for obesity.
Similar content being viewed by others
References
Kopelman PG. Obesity as a medical problem. Nature 2000; 404: 635–43.
Liu YJ, Araujo S, Recker RR, Deng HW. Molecular and genetic mechanisms of obesity: implications for future management. Curr Mol Med 2003; 3: 325–40.
Um JY, Kim HM, Mun SW, Song YS, Hong SH. Interleukin-1 receptor antagonist gene polymorphism and traditional classification in obese women. Int J Neurosci 2006; 116: 39–53.
Um JY, Chung HS, Song MY, Shin HD, Kim HM. Association of the interleukin-1beta gene polymorphism with body mass index in women. Clin Chem 2004; 50: 647–50.
Price SR, Mizel SB, Pekala PH. Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. Biochim Biophys Acta 1986; 889: 274–81.
Memon RA, Feingold KR, Moser AH, Moser AH, Fuller J, Grunfeld C. Regulation of fatty and transport protein and fatty acid translocase mRNA concentrations by endotoxin and cytokines. Am J Physiol 1998; 274: 210–17.
Plata-Salaman CR, Vasselli JR, Sonti G. Differential responsiveness of obese (fa/fa) and lean (Fa/Fa) Zucker rats to cytokine-induced anorexia. Obes Res 1997; 5: 36–42.
Somm E, Cettour-Rose P, Asensio C, Charollais A, Klein M, Theander-Carrillo C, et al. Interleukin-1 receptor antagonist is upregulated during diet-induced obesity and regulates insulin sensitivity in rodents. Diabetologia 2006; 49: 387–93.
Somm E, Henrichot E, Pernin A, Juge-Aubry CE, Muzzin P, Dayer JM, et al. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. Diabetes 2005; 54: 3503–9.
Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86 base pair tandem repeat. Human Genet 1993; 91: 403–4.
Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994; 8: 1314–25.
Meier CA, Bobbioni E, Gabay C, Assimacopoulos-Jeannet F, Golay A, Dayer JM. IL-1 receptor antagonist serum concentrations are increased in human obesity: a possible link to the resistance to leptin? J Clin Endocrinol Metab 2002; 87: 1184–8.
Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1998; 16: 1215.
Bioque G, Crusius JBA, Koutroubakis I, Bouma G, Kostense PJ, Meuwissen SGM, Pena AS. Allelic polymorphism in IL-1β and IL-1 receptor antagonist (IL-1 Ra) genes in inflammatory bowel disease. Clin Exp Immunol 1995; 102: 379–83.
Arner P. Obesity a genetic disease of adipose tissue? Br J Nutr 2000; 83: S9-S16.
Bruun JM, Pedersen SB, Kristensen K, Richelsen B. Effects of pro-inflam-matory cytokines and chemokines on leptin production in human adipose tissue in vitro. Mol Cell Endocrinol 2002; 190: 91–9.
Hurme M, Santtila S. IL-1 receptor antagonist (IL-1RA) plasma levels are co- ordinately regulated by both IL-1R and IL-1beta genes. European Journal of Immunology: 28: 2598–2602.
Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, Rothwell NJ. Leptin actions on food intake and body temperature are mediated by IL-1. Proc Natl Acad Sci USA 1999; 96: 7047–52.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manchanda, P.K., Bid, H.K., Achyut, B.R. et al. Interleukin-1 receptor antagonist gene polymorphism and obesity: A pilot study from north India. Indian J Clin Biochem 22, 61–64 (2007). https://doi.org/10.1007/BF02912883
Issue Date:
DOI: https://doi.org/10.1007/BF02912883